Phospholipid-induced in vivo particle migration to enhance pulmonary deposition

Journal of Aerosol Medicine and Pulmonary Drug Delivery

Volumn 21, Issue 4, 2008, Pages 343-350

  Ganguly, Sudipta ^a,d   Moolchandani, Vikas ^a   Roche, Joseph A ^b   Shapiro, Paul S ^a   Somaraju, Shailaja ^c   Eddington, Natalie D ^a   Dalby, Richard N ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF PHARMACY   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^c Next Breath LLC   (United States)

^d MERCK RESEARCH LABORATORIES   (United States)

Author keywords

Exogenous surfactants; Fluorescent latex beads; Morphometric techniques; Particle migration; Phospholipids; Pulmonary deposition; Rat intranasal instillation; Surface tension

Indexed keywords

BERACTANT; PHOSPHOLIPID; SURFACTANT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG INSTILLATION; FOOD AND DRUG ADMINISTRATION; HISTOPATHOLOGY; IN VIVO STUDY; MALE; NONHUMAN; RAT; RESPIRATORY DISTRESS SYNDROME;

ADMINISTRATION, INTRANASAL; ANIMALS; BIOLOGICAL PRODUCTS; DRUG DELIVERY SYSTEMS; LATEX; LUNG; MALE; PHOSPHOLIPIDS; RATS; RATS, SPRAGUE-DAWLEY; TISSUE DISTRIBUTION;

EID: 57149104806     PISSN: 19412711     EISSN: 19412703     Source Type: Journal    
DOI: 10.1089/jamp.2007.0675     Document Type: Article

References (11)

1. Steimer A, Haltner E, and Lehr CM: Cell culture models of the respiratory tract relevant to pulmonary drug delivery. J Aerosol Med. 2005;18:137-182.
2. Dalby R, Suman J: Inhalation therapy: technological milestones in asthma. Adv Drug Del Rev 2003;55:779-791.
3. Sakagami M: Pulmonary insulin: a critical review of its biopharmaceutics. In: RN Dalby, P Byron, J Peart, and S Farr (eds). Respiratory Drug Delivery VIII. DHI Publishing, Godalming, Surrey, pp. 69-78, 2002.
4. Rodriguez RJ: Management of respiratory distress syndrome: an update. Respir Care. 2003;48:279-287.
5. Ganguly S, Shapiro PS, Somaraju S, and Dalby RN: An in vitro technique for evaluating exogenous surfactants. In: RN Dalby, PR Byron, J Peart, and JD Suman (eds). Respiratory Drug Delivery Europe. DHI Publishing, Godalming, Surrey, pp. 277-280, 2005.
6. Girodet P, and Molimard M: Pharmacological approach to evaluate aerosol pulmonary deposition. J Aerosol Med. 2005;18:183-192.
7. Šimáček I, Martinická F, and Jurdák P: Quantification of the magnetic dust deposition in the magnetopneumographic diagnostic of the human respiratory tract. Meas Sci Rev. 2005;5:57-61.
8. Geiser M, Cruz-Orive LM, Waber U, Im Hof V, and Gehr P: Particle retention in airways estimated by unbiased stereology and photometry. J Aerosol Med. 1995;8:149-165.
9. Southam DS, Dolovich M, O'Byrne PM, and Inman MD: Distribution of intranasal instillations in mice: effects of volume, time, body position and anesthesia. Am J Physiol Lung Cell Mol Physiol. 2002;282:L833-L839.
10. Espinosa FF, and Kamm RD: Bolus dispersal through lungs in surfactant replacement therapy. J Appl Physiol 1999;86:391-410.
11. Mikhailov A, and Meinköhn D: Self-motion in physicochemical systems far from thermal equilibrium. In: L Schimansky-Geier, and T Pöschel (eds). Stochastic Dynamics. Springer, Berlin, pp. 334-345, 1997.